A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients
NCT05956418
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypovolemic Shock
Interventions
DRUG:
Centhaquine
Sponsor
Pharmazz, Inc.